Biotech stock market news

BioTech Stock News in Video : Valeant (NYSE:VRX) vs Allergan (NYSE:AGN) Takeover Battle, Medtronic (NYSE:MDT) + Covidien (NYSE:COV) $45 Billion Deal in Video + GMO Experiments

A source familiar with the matter said on Saturday, Medical-device maker Medtronic Inc and rival Covidien, are in advanced talks to combine in a deal valued at $45 billion to $50 billion. The person said, asking not to be named because the matter is not public, the deal, which would allow Medtronic to be domiciled in Ireland where Covidien is based and thus take advantage of lower tax rates, could come as soon as Monday. Minneapolis-based Medtronic, which makes cardiovascular and orthopedic devices, has a market value of about $61 billion.

An executive vice-president of Valeant Pharmaceuticals International Inc will leave the company, even as the Canadian drugmaker fends off criticism about management turnover from its takeover target Allergan Inc . Valeant confirmed late on Friday after inquiries by Reuters, Executive vice-president and company group chairman Ryan Weldon will leave. Like Chief Executive Mike Pearson, Weldon previously worked for management consulting firm McKinsey & Co. Valeant said Weldon’s departure was planned, and takes effect after it completes a $1.4 billion sale of several injectable treatments to Nestle SA.

Before residents in southern Oregon overwhelmingly voted to ban genetically modified crops last month, farmers negotiated for months with a biotech company that grows engineered sugar beets near their fields. Their goal was to set up a system to peacefully coexist, an online mapping database of fields to help growers minimize cross-pollination between engineered and non-engineered crops. But the effort between farmers and Swiss company Syngenta failed, leading to the ban. Last October, Oregon Gov. John Kitzhaber directed the state’s Department of Agriculture to undertake something far more ambitious than that failed mapping effort — map GMO field locations across the entire state and establish buffer zones and exclusion areas for GE crops.

Continue reading “BioTech Stock News in Video : Valeant (NYSE:VRX) vs Allergan (NYSE:AGN) Takeover Battle, Medtronic (NYSE:MDT) + Covidien (NYSE:COV) $45 Billion Deal in Video + GMO Experiments”

Bullish Stocks: Allergan (NYSE:AGN), Comcast Corporation (NASDAQ:CMCSA), Novartis AG (ADR) (NYSE:NVS), The Walt Disney Company (NYSE:DIS)

Valeant, meanwhile, announced a bid to buy Allergan Inc. (NYSE:AGN) for $45.7 billion, part of its announced strategy to join the ranks of the world’s five biggest drugmakers. Allergan, Inc. (NYSE:AGN) stock performance was 15.25% in last session and finished the day at $163.65. Traded volume was 32.43million shares in the last session and the average volume of the stock remained 3.08million shares. The beta … Continue reading Bullish Stocks: Allergan (NYSE:AGN), Comcast Corporation (NASDAQ:CMCSA), Novartis AG (ADR) (NYSE:NVS), The Walt Disney Company (NYSE:DIS)

Drug Stocks In News: Teva Pharmaceutical Industries (NYSE:TEVA), Allergan (NYSE:AGN), Dynavax Technologies Corporation (NASDAQ:DVAX), ISIS Pharmaceuticals (NASDAQ:ISIS)

Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announces the launch of the generic equivalent to Lunesta(R) (Eszopiclone Tablets, CIV), 1, 2 and 3 mg, in the United States. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance was -0.68% in last session and finished the day at $49.61. Traded volume was 2,806.00million shares in the last session and the average volume of the stock remained 7.21million shares. … Continue reading Drug Stocks In News: Teva Pharmaceutical Industries (NYSE:TEVA), Allergan (NYSE:AGN), Dynavax Technologies Corporation (NASDAQ:DVAX), ISIS Pharmaceuticals (NASDAQ:ISIS)

Healthcare Unusual Volume: Edwards Lifesciences Corp (NYSE:EW), Allergan (NYSE:AGN), Akebia Therapeutics (NASDAQ:AKBA), Acorda Therapeutics (NASDAQ:ACOR)

Edwards Lifesciences Corp (NYSE:EW) climbed 11 percent after the company won a court ruling that limited the sale of Medtronic’s (MDT) CoreValve system in the US. Edwards Lifesciences Corp (NYSE:EW) stock performance was 11.00% in last session and finished the day at $81.00. Traded volume was 7.23million shares in the last session and the average volume of the stock remained 1.36million shares. The beta of … Continue reading Healthcare Unusual Volume: Edwards Lifesciences Corp (NYSE:EW), Allergan (NYSE:AGN), Akebia Therapeutics (NASDAQ:AKBA), Acorda Therapeutics (NASDAQ:ACOR)

5 Active Stocks: Halliburton Company (NYSE:HAL), Genworth Financial, Inc. (NYSE:GNW), Allergan Inc. (NYSE:AGN), Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), Western Digital Corporation (NASDAQ:WDC)

Halliburton Company (NYSE:HAL) sweetened its final offer only slightly from its first bid for rival Baker Hughes Inc., but the bump was magnified by a drop in Baker Hughes’s share price during merger talks this autumn between the world’s second- and third-largest oil-field service companies. Halliburton Company (NYSE:HAL) belongs to Basic Materials sector. Its net profit margin is 10.70% and weekly performance is 4.92%. On … Continue reading 5 Active Stocks: Halliburton Company (NYSE:HAL), Genworth Financial, Inc. (NYSE:GNW), Allergan Inc. (NYSE:AGN), Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), Western Digital Corporation (NASDAQ:WDC)

Stock Runners : Regulus Therapeutics Inc. (NASDAQ:RGLS), American Airlines Group Inc. (NASDAQ:AAL), H&R Block, Inc. (NYSE:HRB), Allergan Inc. (NYSE:AGN), Marine Products (NYSE:MPX)

Regulus Therapeutics Inc. (NASDAQ:RGLS) announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell approximately $80,000,000 of shares of its common stock, of which approximately $70,000,000 of shares are being offered by Regulus and approximately $10,000,000 of shares are being offered by an existing stockholder of Regulus, Isis Pharmaceuticals, Inc. Regulus Therapeutics Inc. (NASDAQ:RGLS) belongs to … Continue reading Stock Runners : Regulus Therapeutics Inc. (NASDAQ:RGLS), American Airlines Group Inc. (NASDAQ:AAL), H&R Block, Inc. (NYSE:HRB), Allergan Inc. (NYSE:AGN), Marine Products (NYSE:MPX)